234242 HIV/AIDS Programming, Health Reform and Public Health

Saturday, November 6, 2010 : 1:10 PM - 1:30 PM

Mildred Williamson, PhD, MSW , Office of Women's Health, Illinois Department of Public Health, Chicago, IL
  
HIV/AIDS is a disease with a global impact including in the United States. The public health response to it remains strongly influenced by an informed and engaged constituency since the early days of the epidemic. Highly organized advocacy at the patient, service provider, community and legislative levels resulted in significant resources allocated for HIV prevention, care and research initiatives nationally and globally. These programs, especially the Ryan White CARE Act, initially enacted by Congress in 1990, continue to serve as a lifeline for people living with HIV/AIDS in the USA who have no other means of support. An overview and analysis of health reform will be made, as there are potentially positive outcomes and significant quality and access challenges for people living with HIV/AIDS that may occur as a result of health reform policies.

Learning Areas:
Advocacy for health and health education
Planning of health education strategies, interventions, and programs
Program planning

Learning Objectives:
Describe the Ryan White CARE Act. Identify features of health reform that will likely have positive benefits. Identify other features that will potentially challenge access and quality of health and social services for people living with HIV/AIDS in the United States.

Keywords: HIV/AIDS, Health Care Reform

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am Chief of the HIV/AIDS section for the Illinois Dept of Public Health and responsible foroversight of the HIV surveillance, prevention, and care programs for the State of Illinois
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 1000.4: Protecting Impacted Public Health Programs